![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif)
Pharmacoeconomic Considerations in Pharmaceutical Company Promotions
Gerald B. Rosenberg
Arch Fam Med. 1995;4(8):674-675.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Goldstein AO, Ives TJ. Pharmacoeconomic considerations in pharmaceutical company promotions. Arch Fam Med. 1994;3:1034.
FREE FULL TEXT
2. IMS America, Ltd. National Prescription Audit Plus. Plymouth Meeting, Pa: IMS America Ltd; 1994.
|